Inspections, Compliance, Enforcement, and Criminal Investigations
IVF Phoenix - Close Out Letter 7/18/11
| Public Health Service Food and Drug Administration |
| Los Angeles District Pacific Region 19701 Fairchild Irvine, CA 92612-2506 Telephone: 949-608·2900 FAX: 949·608-4415 |
CERTIFIED MAIL
RETURN RECEIPT REQUESTED
July 18, 2011
John L. Couvaras, M.D.
dba IVF Phoenix
9817 N. 95th St., Bldg. 1-105
Scottsdale, AZ 85258
Dear Dr. Couvaras:
The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter WL # 12-10, dated 03/29/10. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/s/
Alonza E. Cruse
District Director
Los Angeles District





Department of Health and Human Services

